Thanks for that update, SorcererGuru44. I never finished reading the filing. If Durrant is no longer CEO of Humanigen, that would not stop our progress. We could see Dale's entities buy shares in Taran, if necessary. I don't think they'll go that route. I can't see the judge allowing the shares to be dissolved, if there was a proposed merger. Nor can I see why he would have expanded the number of Milestone Events, and increased the amount of the payments. It seems to me that the share structure is the most likely asset to be leveraged to meet the amended expansion of recovery.